Cambridge Healthtech Institute's 12th Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech.
Domainex will be showcasing FragmentBuilder on our exhibition stand, and presenting a case study on the lysine methyltransferase, G9a as part of the Fragment-based drug discovery track of the conference.
Chief Operating Officer, Dr Tom Mander will be at the event and looks forward to discussing how Domainex can support your drug discovery programme. If you would like to arrange a meeting with Tom at Drug Discovery Chemistry, please get in touch.
We look forward to seeing you there.